Press Releases

Debiopharm and Repare Therapeutics Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer

Le 8e Challenge Qualité de vie du patient récompense BOOTIS.CH, plateforme d’organisation de voyages pour les personnes souffrant d’un handicap

Debiopharm invests over 30 million on innovation when its workforce jumped 33% in Valais in one year

Transfer of Marketing Authorization of Anticancer Drug Elplat® to Takata Pharmaceutical

Debiopharm Innovation Fund Launches New Seed Funding Activity to accelerate digital transformation of cancer care and Pharma R&D

Debiopharm Recognizes Pioneering Japanese Cancer Research During The 82nd JCA-Mauvernay Award Ceremony

Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers

Debiopharm joins discussions with international health organisations to fight anti-microbial resistance at the 2023 World AMR Congress

Debiopharm Launches “Oncolifestyle” website in Switzerland for People Living with Cancer